徐 洁,孙立新,遇 珑.单克隆抗体12H6的靶抗原在肺癌细胞中的表达及功能研究[J].中国肿瘤,2013,22(2):120-125.
单克隆抗体12H6的靶抗原在肺癌细胞中的表达及功能研究
Study on Expression and Function of Targeted Antigen of Anti-lung Cancer Monoclonal Antibody 12H6
投稿时间:2012-11-28  
DOI:10.11735/j.issn.1004-0242.2013.02.A2012345
中文关键词:  肺癌  功能性单克隆抗体  靶向治疗
英文关键词:lung cancer  functional monoclonal antibody  targeted therapy
基金项目:国家自然科学基金(81172033);重大新药创制科技重大专项(2011ZX09102?鄄010?鄄02和2011ZX09401?鄄030)
作者单位
徐 洁 广西医科大学附属肿瘤医院 
孙立新 中国医学科学院北京协和医学院肿瘤研究所 分子肿瘤学国家重点实验室 
遇 珑 中国医学科学院北京协和医学院肿瘤研究所 分子肿瘤学国家重点实验室 
摘要点击次数: 2311
全文下载次数: 1133
中文摘要:
      摘 要: [目的] 分析抗肺癌单抗12H6的靶抗原在肺癌细胞系和肺癌组织中的表达,研究单抗12H6体内外生物学功能。[方法] 细胞免疫荧光、流式细胞荧光法检测单抗12H6靶抗原在3种肺癌细胞系中的表达及其定位,免疫组化法检测其在人肺癌组织中表达及特异性;Transwell法和CCK-8法分别检测12H6体外对肺癌细胞系侵袭和增殖功能的影响。共接种模型裸鼠体内治疗实验研究12H6对移植瘤生长的抑制作用。[结果] 单抗12H6的靶抗原在人肺腺癌细胞(A549、GLC-82)、人肺鳞癌细胞(GLC-P)的胞内及胞膜均有表达,在3种细胞系胞膜的表达比例分别为31.2%、15.4%和16.7%。单抗12H6在人肺癌组织中的表达比例为80.6%,较配对癌旁组织显著上调。单抗12H6在体外能明显抑制肺癌细胞侵袭和增殖;体内能明显抑制移植瘤生长,抑制率为40%。[结论] 单抗12H6具有优良的体内外抑瘤功能,可能为肺癌靶向治疗提供潜在的靶向治疗药物。
英文摘要:
      Abstract:[Purpose] To investigate the expression of the targeted antigen of anti-lung cancer monoclonal antibody 12H6 in lung cancer cell lines and lung cancer tissues,and to study the biological function of 12H6 mAb in vivo and in vitro.[Methods] The expression and localization of targeted antigen in 3 lung cancer cell lines were examined by immunofluorescence and flow cytometry.Expression and specificity of 12H6 mAb in lung cancer tissues were examined by immunohistochemistry. Transwell and CCK-8 assay were performed to evaluate the function of 12H6 mAb against invasion and proliferation of lung cancer cell lines in vitro. Treatment experiment of co-inoculation model to nude mouse was performed to evaluate the inhibitory function of 12H6 mAb against the growth of transplantation tumor. [Results] The targeted antigen of 12H6 mAb were expressed in the cytoplasm and cell membrane of human lung adenocarcinoma cell lines(A549、GLC-82) and squamous carcinoma cell lines(GLC-P) . The expression rates at cell membrane of the 3 cell lines were 31.2%、15.4%、16.7% respectively. The expression of targeted antigen in lung cancer tissues was 80.6%, which was significantly up-regulated compared with paracancerious tissues. The 12H6 mAb obviously inhibited proliferation,invasion of lung cancer cells in vitro and growth of transplantation tumor in vivo with inhibitory rate of 40%.[Conclusions] 12H6 mAb has excellent anti-tumor function in vivo and in vitro,and might be a potential agent in targeted therapy for lung cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器